Induction Therapy with Crizotinib Before Surgery for ROS1 Fusion-Positive Potentially Resectable Non-small Cell Lung Cancer. Li Z, Yang Z, Liu C. Ann Surg Oncol 2025 Sep 27. doi: 10.1245/s10434-025-18402.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Z, Yang Z, Liu C. Induction Therapy with Crizotinib Before Surgery for ROS1 Fusion-Positive Potentially Resectable Non-small Cell Lung Cancer. Ann Surg Oncol 2025 Sep 27. doi: 10.1245/s10434-025-18402.
PMID: 41015625